MA45686A - Formes salines de 4-cyano-n-(2-(4,4-diméthylcyclohex-1-en-1-yl)-6-(2,2,6,6-tétraméthyltétrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide - Google Patents

Formes salines de 4-cyano-n-(2-(4,4-diméthylcyclohex-1-en-1-yl)-6-(2,2,6,6-tétraméthyltétrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide

Info

Publication number
MA45686A
MA45686A MA045686A MA45686A MA45686A MA 45686 A MA45686 A MA 45686A MA 045686 A MA045686 A MA 045686A MA 45686 A MA45686 A MA 45686A MA 45686 A MA45686 A MA 45686A
Authority
MA
Morocco
Prior art keywords
tetramethyltetrahydro
dimethylcyclohex
pyran
carboxamide
pyridin
Prior art date
Application number
MA045686A
Other languages
English (en)
Inventor
David Breslin
Nagy E Fawzy
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA45686A publication Critical patent/MA45686A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA045686A 2016-07-18 2017-07-17 Formes salines de 4-cyano-n-(2-(4,4-diméthylcyclohex-1-en-1-yl)-6-(2,2,6,6-tétraméthyltétrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide MA45686A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662363657P 2016-07-18 2016-07-18

Publications (1)

Publication Number Publication Date
MA45686A true MA45686A (fr) 2019-05-22

Family

ID=59631848

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045686A MA45686A (fr) 2016-07-18 2017-07-17 Formes salines de 4-cyano-n-(2-(4,4-diméthylcyclohex-1-en-1-yl)-6-(2,2,6,6-tétraméthyltétrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide

Country Status (7)

Country Link
US (4) US10266522B2 (fr)
EP (1) EP3484873A1 (fr)
AR (1) AR109080A1 (fr)
MA (1) MA45686A (fr)
TW (1) TW201811326A (fr)
UY (1) UY37339A (fr)
WO (1) WO2018017446A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6530173B2 (ja) * 2014-10-27 2019-06-12 株式会社ブリヂストン タイヤ
WO2018182527A1 (fr) * 2017-03-30 2018-10-04 National University Of Singapore Procédé de traitement de complications inflammatoires dans des maladies oculaires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
JO3240B1 (ar) * 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
ES2658773T3 (es) 2012-08-07 2018-03-12 Janssen Pharmaceutica N.V. Procedimiento de sulfonilación usando fluoruro de nonafluorobutanosulfonilo
US20140151258A1 (en) * 2012-12-03 2014-06-05 Cryovac, Inc. Polymeric Films Comprising Biodegradable Polyester or Copolymer Thereof
WO2014151258A1 (fr) * 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv Dérivés de pyridine substitués utiles en tant qu'inhibiteurs de kinase c-fms

Also Published As

Publication number Publication date
US20200140421A1 (en) 2020-05-07
US20190194175A1 (en) 2019-06-27
TW201811326A (zh) 2018-04-01
WO2018017446A1 (fr) 2018-01-25
US10858348B2 (en) 2020-12-08
AR109080A1 (es) 2018-10-24
US20180016264A1 (en) 2018-01-18
EP3484873A1 (fr) 2019-05-22
US10266522B2 (en) 2019-04-23
US10562892B2 (en) 2020-02-18
US20210053951A1 (en) 2021-02-25
UY37339A (es) 2018-01-31

Similar Documents

Publication Publication Date Title
IL280573A (en) 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
CY1125484T1 (el) Ετεροκυκλικα αμιδια χρησιμα ως διαμορφωτες πρωτεϊνων
EP3500392A4 (fr) Finition de vêtement au laser
EP3454856A4 (fr) Dégronimères hétérocycliques pour la dégradation de protéines cibles
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
MA41140A (fr) Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
MA42592A (fr) Utilisation de dérivés de 2-(pyrazolopyridin-3-yl) pyrimidine en tant qu'inhibiteurs de jak
EP3828174A4 (fr) Dérivé de pyridazinone
FR3056393B1 (fr) Orthese d'extension de machoires
MA47736A (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
DK3642210T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
PT3625224T (pt) Derivados de indol n-substituídos
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
EP3403655A4 (fr) Composition pour augmenter l'expression de pgc-1
DK3450436T3 (da) Kondenseret heterocyklisk forbindelse
EP3409658A4 (fr) Dérivé de tétrahydronaphtalène
EP3333163A4 (fr) Dérivé de guanidine substitué
EP3765445C0 (fr) Dérivés spiro de cyclohexanedione en tant qu'herbicides
EP3337804A4 (fr) Bioconjugués de composés hétérocycliques
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
EP3444345A4 (fr) Dérivé d'arnmicro-143
DK3423060T3 (da) Imatinib til anvendelse til behandling af slagtilfælde
EP3413892A4 (fr) Dérivés de tétrahydroisoquinoline
EP3486231A4 (fr) Dérivé de pyrrolidine servant d'agoniste de ppar